Biotech firm Atomwise used this deck to raise $123m in its series B round

Mar 23, 2021 | Funding




Atomwise uses deep learning AI technology for structure-based drug discovery.



Source link

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.